Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Pierce David A, Director. Officer active across 2 companies, notably Boston Scientific CORP. In total, 14 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €365k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 28 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Pierce David A is Executive Vice President and Director, with 14 filings in total. The 14 sampled filings span from 2016-01-05 to 2023-06-06, with EUR 364588 of sales and the most frequent transaction nature listed as option exercise. He is also linked to Boston Scientific CORP, where the role is EVP Pres MedSurg, and to Diversified Healthcare Trust, where the role is Director.